Abbasifard, M., Taghipoor, M., Talab, M. K., & Khorramdelazad, H. (2025). Immune checkpoint inhibitor-related arthritis and oral disorders: Shared pathophysiology and clinical implications for rheumatology and oral health. Cancer Cell International, 25(1), Article 402. https://doi.org/10.1186/s12935-025-04040-1
Al-Kaif, L. A. I. K., Al-Ameri, H., Alfatlawi, W. R. O., Mahdi, A. E., Al-Khafaji, Y. A. K., Al-Saadi, M. A., Al-Charrakh, A. H., Al-Mammori, R. T., & Akkaif, M. A. (2024). Detection of CTLA-4 level and humeral immune response after the second dose of COVID-19 vaccine in certain Iraqi provinces participants. PLoS ONE, 19(1), Article e0296521. https://doi.org/10.1371/journal.pone.0296521
Ancin, B., Özercan, M. M., Yilmaz, Y. M., Uysal, S., Kumbasar, U., Saribas, Z., Dikmen, E., Dogan, R., & Demircin, M. (2022). The correlation of serum sPD-1 and sPD-L1 levels with clinical, pathological characteristics and lymph node metastasis in nonsmall cell lung cancer patients. Turkish Journal of Medical Sciences, 52(4), 1050-1057. https://doi.org/10.55730/1300-0144.5407
Brook, I. (2003). Microbiology and management of chronic suppurative otitis media in children. Journal of Tropical Pediatrics, 49(4), 196-199. https://doi.org/10.1093/tropej/49.4.196
Bwire, G. M., Majigo, M. V., Njiro, B. J., & Mawazo, A. (2021). Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis. Journal of Medical Virology, 93(2), 719-725. https://doi.org/10.1002/jmv.26349
Chang, K., Svabek, C., Vazquez-Guillamet, C., Sato, B., Rasche, D., Wilson, S., Robbins, P., Ulbrandt, N., Suzich, J., Green, J., Patera, A. C., Blair, W., Krishnan, S., & Hotchkiss, R. (2014). Targeting the programmed cell death 1: Programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Critical Care, 18(1), Article R3. https://doi.org/10.1186/cc13176
Durmaz, B., Abdulmajed, O., Durmaz, R., Koroglu, M., Arı, O., Celik, S., & Kalcioglu, M. T. (2021). Respiratory viruses in the healthy middle ear and middle ear with otitis media with effusion. Journal of Medical Virology, 93(11), 6140-6147. https://doi.org/10.1002/jmv.27151
Frazier, K. M., Hooper, J. E., Mostafa, H. H., & Stewart, C. M. (2020). SARS-CoV-2 virus isolated from the mastoid and middle ear: Implications for COVID-19 precautions during ear surgery. JAMA Otolaryngology-Head & Neck Surgery, 146(10), 964-966. https://doi.org/10.1001/jamaoto.2020.1922 (Correction published 2020, October 1, JAMA Otolaryngology-Head & Neck Surgery, 146(10), 982. https://doi.org/10.1001/jamaoto.2020.2950)
Gao, Z., Feng, Y., Xu, J., & Liang, J. (2022). T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy. Frontiers in Immunology, 13, Article 977394. https://doi.org/10.3389/fimmu.2022.977394
George, D., & Mallery, P. (2018). IBM SPSS Statistics 25 step by step: A simple guide and reference (15th ed.). Routledge. https://doi.org/10.4324/9781351033909
Goh, D., Lim, J. C. T., Fernandez, S. B., Joseph, C. R., Edwards, S. G., Neo, Z. W., Lee, J. N., Caballero, S. G., Lau, M. C., & Yeong, J. P. S. (2022). Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Frontiers in Immunology, 13, Article 939989. https://doi.org/10.3389/fimmu.2022.939989
Heikkinen, T., & Chonmaitree, T. (2000). Viral-bacterial synergy in otitis media: Implications for management. Current Infectious Disease Reports, 2(2), 154-159. https://doi.org/10.1007/s11908-000-0028-6
Hiremath, B., Mudhol, R. S., & Vagrali, M. A. (2019). Bacteriological profile and antimicrobial susceptibility pattern in chronic suppurative otitis media: A 1-year cross-sectional study. Indian Journal of Otolaryngology and Head & Neck Surgery, 71(Suppl. 2), 1221-1226. https://doi.org/10.1007/s12070-018-1279-6
Huang, H. C., Wang, S. H., Fang, G. C., Chou, W. C., Liao, C. C., Sun, C. P., Jan, J. T., Ma, H. H., Ko, H. Y., Ko, Y. A., Chiang, M. T., Liang, J. J., Kuo, C. T., Lee, T. A., Morales-Scheihing, D., Shen, C. Y., Chen, S. Y., McCullough, L. D., Cui, L., ... Li, C. W. (2023). Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion. Journal of Medical Virology, 95(2), Article e28478. https://doi.org/10.1002/jmv.28478
Jotic, A., Cirkovic, I., Jovicic, N., Bukurov, B., Krca, N., & Savic Vujovic, K. (2025). Biofilm formation and its relationship with the microbiome in pediatric otitis media. Microorganisms, 13(12), Article 2760. https://doi.org/10.3390/microorganisms13122760
Jubel, J. M., Barbati, Z. R., Burger, C., Wirtz, D. C., & Schildberg, F. A. (2020). The role of PD-1 in acute and chronic infection. Frontiers in Immunology, 11, Article 487. https://doi.org/10.3389/fimmu.2020.00487
Juhn, S. K., Jung, M. K., Hoffman, M. D., Drew, B. R., Preciado, D. A., Sausen, N. J., Jung, T. T., Kim, B. H., Park, S. Y., Lin, J., Ondrey, F. G., Mains, D. R., & Huang, T. (2008). The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clinical and Experimental Otorhinolaryngology, 1(3), 117-138. https://doi.org/10.3342/ceo.2008.1.3.117
Kaye, K. S., Harris, A. D., Samore, M., & Carmeli, Y. (2005). The case-case-control study design: Addressing the limitations of risk factor studies for antimicrobial resistance. Infection Control & Hospital Epidemiology, 26(4), 346-351. https://doi.org/10.1086/502550
Mair, M. J., Pajenda, S., Ilhan-Mutlu, A., Steindl, A., Kiesel, B., Widhalm, G., Dieckmann, K., Feldmann, K., Hainfellner, J., Marosi, C., Mullauer, L., Wagner, L., Preusser, M., & Berghoff, A. S. (2020). Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours. ESMO Open, 5(6), Article e000863. https://doi.org/10.1136/esmoopen-2020-000863
Marom, T., Nokso-Koivisto, J., & Chonmaitree, T. (2012). Viral-bacterial interactions in acute otitis media. Current Allergy and Asthma Reports, 12(6), 551-558. https://doi.org/10.1007/s11882-012-0303-2
Mijwel, H. K., Salman, S. M., & Al-Charrakh, A. H. (2023). Effects of empagliflozin on a model of chronic depression and brain Toll-like receptors gene expression in male rats. Medical Journal of Babylon, 20(2), 399-405. https://doi.org/10.4103/MJBL.MJBL_275_23
Moon, J. W., Kong, S. K., Kim, B. S., Kim, H. J., Lim, H., Noh, K., Kim, Y., Choi, J. W., Lee, J. H., & Kim, Y. S. (2017). IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma. Scientific Reports, 7(1), Article 17810. https://doi.org/10.1038/s41598-17-18132-0
Muñoz-Cobo, B., Solano, C., Nieto, J., de la Cámara, R., Remigia, M. J., Garcia-Noblejas, A., López, J., Benet, I., Hernández-Boluda, J. C., Costa, E., Bravo, D., & Navarro, D. (2011). Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection. Bone Marrow Transplantation, 46(11), 1484-1486. https://doi.org/10.1038/bmt.2010.322
Niu, M., Liu, Y., Yi, M., Jiao, D., & Wu, K. (2022). Biological characteristics and clinical significance of soluble PD-1/PD-L1 and exosomal PD-L1 in cancer. Frontiers in Immunology, 13, Article 827921. https://doi.org/10.3389/fimmu.2022.827921
Pan, X., Zhong, A., Xing, Y., Shi, M., Qian, B., Zhou, T., Chen, Y., & Zhang, X. (2016). Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion. Experimental and Therapeutic Medicine, 12(4), 2161-2168. https://doi.org/10.3892/etm.2016.3611
Qureishi, A., Lee, Y., Belfield, K., Birchall, J. P., & Daniel, M. (2014). Update on otitis media - prevention and treatment. Infection and Drug Resistance, 7, 15-24. https://doi.org/10.2147/IDR.S39637
Schönrich, G., & Raftery, M. J. (2019). The PD-1/PD-L1 axis and virus infections: A delicate balance. Frontiers in Cellular and Infection Microbiology, 9, Article 207. https://doi.org/10.3389/fcimb.2019.00207
Serban, R., Filip, C., Radulescu, L. M., Badescu, M. C., Badescu, M. M., Diaconescu, B. M., Cobzeanu, M. D., & Cobzeanu, B. M. (2021). IL-1α, IL-6 and IL-8 serum values in patients with chronic suppurative otitis media. Experimental and Therapeutic Medicine, 22(5), Article 1226. https://doi.org/10.3892/etm.2021.10660
Torretta, S., Rosazza, C., Baselli, L., Berti, C., Bosi, P., Dellepiane, R. M., Folino, F., Milani, G. P., & Marchisio, P. (2022). Immunological profiles of children with recurrent otitis media with or without spontaneous tympanic membrane perforation and of children with recurrent respiratory infections. International Journal of Pediatric Otorhinolaryngology, 160, Article 111219. https://doi.org/10.1016/j.ijporl.2022.111219
World Medical Association. (2013). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310(20), 2191-2194. https://doi.org/10.1001/jama.2013.281053
Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., Hu, Y., Tao, Z. W., Tian, J. H., Pei, Y. Y., Yuan, M. L., Zhang, Y. L., Dai, F. H., Liu, Y., Wang, Q. M., Zheng, J. J., Xu, L., Holmes, E. C., & Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265-269. https://doi.org/10.1038/s41586-020-2008-3
Wykes, M. N., & Lewin, S. R. (2018). Immune checkpoint blockade in infectious diseases. Nature Reviews Immunology, 18(2), 91-104. https://doi.org/10.1038/nri.2017.112
Yuan, Y., Luo, Y., Wu, C., & Zhang, W. (2022). Prognostic factors of hearing outcome in patients with chronic suppurative otitis media following tympanoplasty: A retrospective cohort study. Annals of Translational Medicine, 10(21), Article 1169. https://doi.org/10.21037/atm-22-4800
Zhao, T., Li, Y., Zhang, J., & Zhang, B. (2020). PD-L1 expression increased by IFN-γ via JAK2-STAT1 signaling and predicts a poor survival in colorectal cancer. Oncology Letters, 20(2), 1127-1134. https://doi.org/10.3892/ol.2020.11647